Bozhi Ye

2.1k total citations
63 papers, 1.6k citations indexed

About

Bozhi Ye is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Bozhi Ye has authored 63 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 14 papers in Cardiology and Cardiovascular Medicine and 12 papers in Epidemiology. Recurrent topics in Bozhi Ye's work include Inflammasome and immune disorders (24 papers), Ubiquitin and proteasome pathways (13 papers) and Autophagy in Disease and Therapy (8 papers). Bozhi Ye is often cited by papers focused on Inflammasome and immune disorders (24 papers), Ubiquitin and proteasome pathways (13 papers) and Autophagy in Disease and Therapy (8 papers). Bozhi Ye collaborates with scholars based in China, Thailand and United States. Bozhi Ye's co-authors include Weijian Huang, Zhouqing Huang, Xueli Cai, Jibo Han, Shanshan Dai, Peiren Shan, Zhongqiu Lu, Lin Lü, Shuang Lin and Fanqi Kong and has published in prestigious journals such as Nature Communications, Circulation Research and Hypertension.

In The Last Decade

Bozhi Ye

60 papers receiving 1.6k citations

Peers

Countries citing papers authored by Bozhi Ye

Since Specialization

Citations

This map shows the geographic impact of Bozhi Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bozhi Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bozhi Ye more than expected).

Fields of papers citing papers by Bozhi Ye

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bozhi Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bozhi Ye. The network helps show where Bozhi Ye may publish in the future.

Co-authorship network of co-authors of Bozhi Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Bozhi Ye. A scholar is included among the top collaborators of Bozhi Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bozhi Ye. Bozhi Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ubiquitin‐specific protease 25 improves myocardial ischemia–reperfusion injury by deubiquitinating NLRP3 and negatively regulating NLRP3 inflammasome activity in cardiomyocytes 2025 ·Clinical and Translational Medicine ·Bozhi Ye, (unknown), Lingfeng Zhong, Yi Wang, Wei Wang, (unknown), Xue Han, (unknown), Gaojun Wu, Wenhai Huang, Guang Liang	4
2	Cardiomyocyte-derived USP13 protects hearts from hypertrophy via deubiquitinating and stabilizing STAT1 in male mice 2025 ·Nature Communications ·Jibo Han, Liming Lin, (unknown), (unknown), Lintao Wang, Bozhi Ye, Xue Han, (unknown), (unknown), Gaojun Wu, Guang Liang, Yi Wang	1
3	USP25 directly interacts with and deubiquitinates PPARα to increase PPARα stability in hepatocytes and attenuate high-fat diet-induced MASLD in mice 2025 ·Cell Death and Differentiation ·(unknown), Weiwei Zhu, Xiang Hu, Ye Lin, (unknown), Qianhui Zhang, Minxiu Wang, Bozhi Ye, (unknown), Yi Wang, Lijiang Huang, (unknown), Guang Liang	3
4	Deubiquitinase USP13 alleviates doxorubicin-induced cardiotoxicity through promoting the autophagy-mediated degradation of STING 2025 ·Acta Pharmaceutica Sinica B ·Liming Lin, Jibo Han, (unknown), (unknown), Bozhi Ye, (unknown), Xue Han, (unknown), (unknown), Gaojun Wu, Guang Liang	1
5	Macrophage-Derived GSDMD Plays an Essential Role in Atherosclerosis and Cross Talk Between Macrophages via the Mitochondria-STING-IRF3/NF-κB Axis 2024 ·Arteriosclerosis Thrombosis and Vascular Biology ·(unknown), Jibo Han, Lingfeng Zhong, (unknown), (unknown), Yucong Zhang, (unknown), Shuang Lin, Zhouqing Huang, Weijian Huang, Xueli Cai, Bozhi Ye	38
6	Emodin Suppresses NLRP3/GSDMD-induced Inflammation via the TLR4/MyD88/NF-κB Signaling Pathway in Atherosclerosis 2024 ·Cardiovascular Drugs and Therapy ·Bozhi Ye, Xueli Cai, (unknown), (unknown), Shanshan Dai, (unknown), Weijian Huang, Lei Zhang, Zixuan Wang, (unknown), (unknown), Zhouqing Huang, (unknown)	9
7	USP25 ameliorates vascular remodeling by deubiquitinating FOXO3 and promoting autophagic degradation of FOXO3 2024 ·Acta Pharmaceutica Sinica B ·(unknown), Bozhi Ye, (unknown), (unknown), (unknown), (unknown), Xue Han, Wu Luo, Chen Chen, Weijian Huang, Hao Zhou, Gaojun Wu, Yi Wang, Guang Liang	0
8	YOD1 regulates microglial homeostasis by deubiquitinating MYH9 to promote the pathogenesis of Alzheimer's disease 2024 ·Acta Pharmaceutica Sinica B ·Jinfeng Sun, Fan Chen, (unknown), Yuqing Zeng, Hao Tang, Bozhi Ye, Wenhua Zheng, Xiong Li, Liwei Li, (unknown), Qin Yu, Linjie Chen, Wei Wang, Guang Liang, (unknown)	6
9	Carnosol attenuates angiotensin II-induced cardiac remodeling and inflammation via directly binding to p38 and inhibiting p38 activation 2024 ·International Immunopharmacology ·(unknown), Bozhi Ye, Liming Lin, (unknown), Yuchen Jiang, (unknown), (unknown), Xue Han, Wei Wang, Gaojun Wu, (unknown), Peiren Shan, Guang Liang	3
10	Endothelial deubiquinatase YOD1 mediates Ang II-induced vascular endothelial-mesenchymal transition and remodeling by regulating β-catenin 2024 ·Acta Pharmacologica Sinica ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Gaojun Wu, Weijian Huang, Bozhi Ye, Guang Liang	8
11	Emodin attenuates cardiomyocyte pyroptosis in doxorubicin-induced cardiotoxicity by directly binding to GSDMD 2023 ·Phytomedicine ·Shanshan Dai, (unknown), (unknown), Jibo Han, Lingfeng Zhong, Yucong Zhang, (unknown), (unknown), Weijian Huang, Lan Su, Zhouqing Huang, Bozhi Ye	22
12	USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes 2023 ·Circulation Research ·Bozhi Ye, Hao Zhou, (unknown), Wu Luo, (unknown), Ying‐Yong Zhao, Jibo Han, Xue Han, Weijian Huang, Gaojun Wu, Xu Wang, Guang Liang	76
13	Deubiquitinase JOSD2 improves calcium handling and attenuates cardiac hypertrophy and dysfunction by stabilizing SERCA2a in cardiomyocytes 2023 ·Nature Cardiovascular Research ·Jibo Han, (unknown), (unknown), Bozhi Ye, (unknown), (unknown), Xue Han, Xu Wang, Gaojun Wu, Yi Wang, Guang Liang	15
14	OTUD6A in tubular epithelial cells mediates angiotensin II-induced kidney injury by targeting STAT3 2023 ·American Journal of Physiology-Cell Physiology ·Xiaoyu Sun, Shuhong Chen, (unknown), Tong Wu, (unknown), Wu Luo, Jibo Han, (unknown), Bozhi Ye, Gang Cao, Shengbin Huang, Guang Liang	6
15	Bicyclol Attenuates Obesity-Induced Cardiomyopathy via Inhibiting NF-κB and MAPK Signaling Pathways 2022 ·Cardiovascular Drugs and Therapy ·(unknown), (unknown), Lingfeng Zhong, (unknown), Bozhi Ye, Zhe Wang, Nipon Chattipakorn, Weijian Huang, Guang Liang, Gaojun Wu	8
16	Oridonin Relieves Angiotensin II-Induced Cardiac Remodeling via Inhibiting GSDMD-Mediated Inflammation 2022 ·Cardiovascular Therapeutics ·Shuang Lin, Shanshan Dai, (unknown), (unknown), (unknown), Weijian Huang, Bozhi Ye, Hong Xia	6
17	Tabersonine alleviates obesity‐induced cardiomyopathy by binding to Transforming growth factor activated kinase 1 (TAK1) and inhibiting TAK1‐mediated inflammation 2022 ·Phytotherapy Research ·(unknown), (unknown), Pan Chen, Bozhi Ye, Wu Luo, Xu Wang, Weijian Huang, Gaojun Wu, Guang Liang	6
18	Inhibition of TAK1/TAB2 complex formation by costunolide attenuates obesity cardiomyopathy via the NF-κB signaling pathway 2022 ·Phytomedicine ·Bozhi Ye, Xudong Chen, (unknown), (unknown), (unknown), (unknown), Nipon Chattipakorn, Weijian Huang, Xu Wang, Gaojun Wu, Guang Liang	14
19	Establishment and Validation of ALPH-Q Score to Predict Mortality Risk in Patients With Acute-on-Chronic Hepatitis B Liver Failure 2015 ·Medicine ·Shengjie Wu, Huadong Yan, (unknown), Keqing Shi, (unknown), Yaoyao Xie, Yu‐Chen Fan, Bozhi Ye, Weijian Huang, Yong‐Ping Chen, Ming‐Hua Zheng	17
20	Association Between Sex-Specific Serum Uric Acid and Non-Alcoholic Fatty Liver Disease in Chinese Adults 2015 ·Medicine ·Shengjie Wu, Gui‐Qi Zhu, Bozhi Ye, Fanqi Kong, (unknown), Hai Zou, Keqing Shi, (unknown), Martin Braddock, Weijian Huang, Yong‐Ping Chen, Ming‐Hua Zheng	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact